Active substance
Results for the substance somapacitan
2 results
About this active substance
Somapacitan is a long-acting human growth hormone analog used in the treatment of growth hormone deficiency (GHD) in adults. It is designed for once-weekly administration, providing a more convenient alternative to traditional therapies that require daily injections.
Somapacitan works by stimulating bone and muscle growth, promoting protein and lipid metabolism, and supporting normal metabolic functions. It is administered as a subcutaneous injection, with the dose adjusted based on individual patient needs and treatment response.
Common side effects include injection site reactions, headache, fatigue, and nausea. In rare cases, severe adverse reactions such as hyperglycemia or fluid retention may occur. Regular monitoring of metabolic parameters and overall health is essential during treatment.
Somapacitan represents a modern therapeutic option for patients with growth hormone deficiency, offering simpler administration and comparable efficacy to conventional therapies.
Somapacitan works by stimulating bone and muscle growth, promoting protein and lipid metabolism, and supporting normal metabolic functions. It is administered as a subcutaneous injection, with the dose adjusted based on individual patient needs and treatment response.
Common side effects include injection site reactions, headache, fatigue, and nausea. In rare cases, severe adverse reactions such as hyperglycemia or fluid retention may occur. Regular monitoring of metabolic parameters and overall health is essential during treatment.
Somapacitan represents a modern therapeutic option for patients with growth hormone deficiency, offering simpler administration and comparable efficacy to conventional therapies.